Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on Pharmacokinetics of Delpazolid in Healthy Males
NCT02538003Phase 1Completed
- Sponsor
- LigaChem Biosciences
- Start
- Sep 2015
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of delpazolid in Tuberculosis (TB) and Gram-positive bacterial infection (2 arms), sponsored by LigaChem Biosciences. Primary endpoint: Number of Adverse events. Started Sep 2015; status: completed.
02
Drugs
delpazolid
03
Conditions
Tuberculosis (TB)Gram-positive bacterial infection
Beyond the preview
Go deeper on NCT02538003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02538003.